Literature DB >> 18492553

Neuropathic pain in cancer.

C E Urch1, A H Dickenson.   

Abstract

Neuropathic pain in cancer arises following injury to peripheral or central neurons, in a similar manner to such pain arising from a non-cancer injury. Much of our knowledge of neuropathic pain is based on peripheral originating events with little known about central neuropathic pain. This article explores some of the similarities and differences between cancer and non-cancer-related neuropathic pain. The neural pathways, ion channels, receptors and neurotransmitters that potentially can be altered in both neuropathies are the same; however the nature of the injury, the timing, repeated injuries and the co-existence of simultaneous non-neuropathic pain states lead to potential unique constellations of neuroreceptor and neurotransmitter expression in the context of cancer pain. This in turn may lead to different clinical presentation of pain sensations and potentially lead to specific treatment options.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492553     DOI: 10.1016/j.ejca.2008.03.015

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  15 in total

Review 1.  Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy.

Authors:  Joyce H Kim; Patrick M Dougherty; Salahadin Abdi
Journal:  Gynecol Oncol       Date:  2015-01-10       Impact factor: 5.482

Review 2.  Spinal cord stimulation in the treatment of cancer-related pain: "back to the origins".

Authors:  Artemus Flagg; Kai McGreevy; Kayode Williams
Journal:  Curr Pain Headache Rep       Date:  2012-08

3.  Treatment of acute and chronic focal neuropathic pain in cancer patients with lidocaine 5 % patches. A radiation and oncology department experience.

Authors:  Escarlata López Ramírez
Journal:  Support Care Cancer       Date:  2012-12-15       Impact factor: 3.603

4.  Neuropathic caner pain: is it linked to the recurrence of cancer?

Authors:  Eun Soo Kim
Journal:  Korean J Pain       Date:  2015-04-01

5.  Cancer-related neuropathic pain in out-patient oncology clinics: a European survey.

Authors:  Cristina Garzón-Rodríguez; Leonidas Lyras; Luis Olay Gayoso; Juan M Sepúlveda; Epaminondas Samantas; Uwe Pelzer; Sarah Bowen; Chantal van Litsenburg; Mette Strand
Journal:  BMC Palliat Care       Date:  2013-11-07       Impact factor: 3.234

6.  Efficacy and tolerability of controlled-release oxycodone for oxaliplatin-induced peripheral neuropathy and the extension of FOLFOX therapy in advanced colorectal cancer patients.

Authors:  Makoto Nagashima; Mitsuru Ooshiro; Ayako Moriyama; Yui Sugishita; Kengo Kadoya; Ayami Sato; Tomoaki Kitahara; Ryuichi Takagi; Tasuku Urita; Yutaka Yoshida; Hiroshi Tanaka; Takashi Oshiro; Shinichi Okazumi; Ryoji Katoh
Journal:  Support Care Cancer       Date:  2014-01-24       Impact factor: 3.603

Review 7.  Neuropathic cancer pain: What we are dealing with? How to manage it?

Authors:  Ece Esin; Suayib Yalcin
Journal:  Onco Targets Ther       Date:  2014-04-17       Impact factor: 4.147

8.  Antinociceptive Effect of Intrathecal Injection of Genetically Engineered Human Bone Marrow Stem Cells Expressing the Human Proenkephalin Gene in a Rat Model of Bone Cancer Pain.

Authors:  Yi Sun; Yuke Tian; Haifeng Li; Dengwen Zhang; Qiang Sun
Journal:  Pain Res Manag       Date:  2017-02-14       Impact factor: 3.037

9.  Quality of Life and Neuropathic Pain in Hospitalized Cancer Patients: A Comparative Analysis of Patients in Palliative Care Wards Versus Those in General Wards.

Authors:  Sungur Ulas; Sibel Eyigor; Ismail Caramat
Journal:  Indian J Palliat Care       Date:  2018 Jul-Sep

10.  Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?

Authors:  Kai-Uwe Kern; Srinivas Nalamachu; Louis Brasseur; Joanna M Zakrzewska
Journal:  J Pain Res       Date:  2013-04-05       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.